A Bayesian-based Approach for Identification of Potential Protein Biomarkers in Hepatocellular Carcinoma
Authors: 
Kangning Zhu, Jing Li, Boya Chen, Xin LiuAuthors Info & Claims
Kangning Zhu, Jing Li, Boya Chen, Xin LiuAuthors Info & ClaimsPages 110 - 119
References
[1]
Siegel, R.L., Miller, K.D. and Jemal, A. (2020) ‘Cancer statistics, 2020’, CA: a cancer journal for clinicians, 70(1), pp. 7–30.
[2]
Sartorius, K. et al. (2015) ‘Global and country underestimation of hepatocellular carcinoma (HCC) in 2012 and its implications’, Cancer Epidemiology, 39(3), pp. 284–290.
[3]
Galle, P.R. et al. (2018) ‘EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma’, Journal of Hepatology, 69(1), pp. 182–236.
[4]
Gentile, I.( 1 ) et al. (2017) ‘Diagnostic accuracy of PIVKA-II, alpha-fetoprotein and a combination of both in diagnosis of hepatocellular carcinoma in patients affected by chronic HCV infection’, In Vivo, 31(4), pp. 695-700–700.
[5]
Carr, B.I. et al. (2018) ‘HCC with low- and normal-serum alpha-fetoprotein levels’, Clinical practice (London, England), 15(1), pp. 453–464.
[6]
Wei, W. et al. (2020) ‘Diagnostic value of plasma HSP90α levels for detection of hepatocellular carcinoma’, BMC Cancer, 20(1).
[7]
Kim, E. and Viatour, P. (2020) ‘Hepatocellular carcinoma: old friends and new tricks’, Experimental & molecular medicine, 52(12), pp. 1898–1907.
[8]
Montagnana, M., Danese, E. and Lippi, G. (2015) ‘Squamous cell carcinoma antigen in hepatocellular carcinoma: Ready for the prime time?’, Clinica Chimica Acta, 445, pp. 161–166.
[9]
Guo, L.Y., Zhu, P. and Jin, X.P. (2016) ‘Association between the expression of HIF-1α and VEGF and prognostic implications in primary liver cancer’, Genetics and Molecular Research, 15(2).
[10]
Piñero, F., Dirchwolf, M. and Pessôa, M.G. (2020) ‘Biomarkers in Hepatocellular Carcinoma: Diagnosis, Prognosis and Treatment Response Assessment’, Cells, 9(6).
[11]
Ye, Q.-H. and Qin, L.-X. (2003) ‘Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning’, Nature Medicine, 9(4), p. 416.
[12]
Shen, J.( 1 ) et al. (2020) ‘Identification of a novel gene signature for the prediction of recurrence in HCC patients by machine learning of genome-wide databases’, Scientific Reports, 10(1).
[13]
Xu W, He H, Guo Z, Li W. (2022) 'Evaluation of machine learning models on protein level inference from prioritized RNA features.' Brief Bioinform, 23(3):bbac091.
[14]
Han, L.( 1 ) et al. (2018) ‘A probabilistic pathway score (PROPS) for classification with applications to inflammatory bowel disease’, Bioinformatics, 34(6), pp. 985-993–993.
[15]
Scutari, M. (2009) ‘Learning Bayesian Networks with the bnlearn R Package’. Available at: https://search-ebscohost-com.ez.xjtlu.edu.cn/login.aspx?direct=true&db=edsarx&AN=edsarx.0908.3817&site=eds-live&scope=site (Accessed: 22 December 2022).
[16]
Gao Q, Zhu H, Dong L, Shi W, Chen R, Song Z, Fan J, (2019) 'Integrated Proteogenomic Characterization of HBV-Related Hepatocellular Carcinoma.' Cell, 179(2):561-577.e22. https://doi.org/10.1016/j.cell.2019.08.052.
[17]
Jiang Y, Sun A, Zhao Y, Ying W, Sun H, Yang X, Li Z, (2019) 'Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma.' Nature, 567(7747):257–261. https://doi.org/10.1038/s41586-019-0987-8.
[18]
Bijlsma, S.( 1 ) et al. (2006) ‘Large-scale human metabolomics studies: A strategy for data (pre-) processing and validation’, Analytical Chemistry, 78(2), pp. 567-574–574.
[19]
Scutari, M. (2009) ‘Learning Bayesian Networks with the bnlearn R Package’. Available at: https://search-ebscohost-com.ez.xjtlu.edu.cn/login.aspx?direct=true&db=edsarx&AN=edsarx.0908.3817&site=eds-live&scope=site (Accessed: 22 December 2022).
[20]
Wu, Y., Huang, T., Li, X. et al. Retinol dehydrogenase 10 reduction mediated retinol metabolism disorder promotes diabetic cardiomyopathy in male mice. Nat Commun 14, 1181 (2023). https://doi.org/10.1038/s41467-023-36837-x
[21]
Chen, H. et al. (2014) ‘Expression of P450 and nuclear receptors in normal and end-stage Chinese livers’, WORLD JOURNAL OF GASTROENTEROLOGY, 20(26), pp. 8681–8690.
[22]
Kurzawski, M. et al. (2012) ‘Expression of genes involved in xenobiotic metabolism and transport in end-stage liver disease: up-regulation of ABCC4 and CYP1B1’, Pharmacological Reports, 64(4), pp. 927–939.
[23]
Ghayee, H.K., Auchus, R.J. Basic concepts and recent developments in human steroid hormone biosynthesis. Rev Endocr Metab Disord 8, 289–300 (2007). https://doi.org/10.1007/s11154-007-9052-2
[24]
Wen Y, Shang Y, Wang Q. Exploration of the Mechanism of Linoleic Acid Metabolism Dysregulation in Metabolic Syndrome. Genom Proteom Bioinform. 2022;2022:6793346.
[25]
Guo J, Villalta P, Weight C, Bonala R, Johnson F, Rosenquist T, Targeted and Untargeted Detection of DNA Adducts of Aromatic Amine Carcinogens in Human Bladder by Ultra-Performance Liquid Chromatography-High-Resolution Mass Spectrometry. Chem Res Toxicol. 2018;31(11):1264-1274.
[26]
Guengerich F. Drug Metabolism: A Half-Century Plus of Progress, Continued Needs, and New Opportunities. Drug Metab Dispos. 2022;50(7):1070-1077.
[27]
Zhou Y, Khan H, Xiao J, Cheang W. Effects of Arachidonic Acid Metabolites on Cardiovascular Health and Disease. Int J Mol Sci. 2021;22(21):12029.
[28]
Guo Z, Ma Y, Wang Y, Xiang H, Yang S-Y, Guo Z, The Role of IL-6 and TMEM100 in Lumbar Discogenic Pain and the Mechanism of the Glycine-Serine-Threonine Metabolic Axis: A Metabolomic and Molecular Biology Study. J Pain Res. 2023;16:1–14.
[29]
Rattanawong K, Koiso N, Toda E, Kinoshita A, Tanaka M, Tsuji H, Regulatory functions of ROS dynamics via glutathione metabolism and glutathione peroxidase activity in developing rice zygote. Plant J. 2021;108(1):206-220.
[30]
Zhou Y, Li X, Long G, Tao Y, Zhou L, Tang J. Identification and validation of a tyrosine metabolism-related prognostic prediction model and characterization of the tumor microenvironment infiltration in hepatocellular carcinoma. Front Immunol. 2022;13:994259.
[31]
Zhang Y, Li Q, Liu Y, The Role of Extracellular Matrix and Its Receptors in the Development and Progression of Gastric Cancer: A Literature Review. Front Immunol. 2022;13:916933.
[32]
Yu, J.( 1 ) et al. (2021) ‘CYP1A2 suppresses hepatocellular carcinoma through antagonizing HGF/MET signaling’, Theranostics, 11(5), pp. 2123-2136–2136.
[33]
Ashida, R.( 1,2 ) et al. (2017) ‘CYP3A4 gene is a novel biomarker for predicting a poor prognosis in hepatocellular carcinoma’, Cancer Genomics and Proteomics, 14(6), pp. 445-453–453.
[34]
Yu, D.( 1,2 ) et al. (2015) ‘Suppression of CYP2C9 by MicroRNA hsa-miR-128-3p in human liver cells and association with hepatocellular carcinoma’, Scientific Reports, 5.
[35]
Zhu, Y. et al. (2020) ‘Clinical significance and function of RDH16 as a tumor‐suppressing gene in hepatocellular carcinoma’, Hepatology Research, 50(1), pp. 110–120.
[36]
Hyuk Soo Eun et al. (2019) ‘Cytochrome P450 4A11 Expression in Hepatocellular Carcinoma’, Gut & Liver, 13(6(suppl. 1)), p. 113. Available at: https://search-ebscohost-com.ez.xjtlu.edu.cn/login.aspx?direct=true&db=asn&AN=141506449&site=eds-live&scope=site (Accessed: 24 December 2022).
[37]
Yu‐Yan Pang et al. (2020) ‘The clinical value and potential molecular mechanism of the downregulation of MAOA in hepatocellular carcinoma tissues’, Cancer Medicine, 9(21), pp. 8004–8019.
[38]
Dai, W. et al. (2020) ‘OGDHL silencing promotes hepatocellular carcinoma by reprogramming glutamine metabolism’, Journal of Hepatology, 72(5), pp. 909–923.
[39]
Chen, S.-L.( 1,3 ) et al. (2019) ‘A GYS2/p53 negative feedback loop restricts tumor growth in HBV-related hepatocellular carcinoma’, Cancer Research, 79(3), pp. 534-545–545.
[40]
Dazhi Tian et al. (2021) ‘A Five-Gene-Based Prognostic Signature for Hepatocellular Carcinoma’, Frontiers in Medicine, 8.
[41]
Xuejun Ai et al. (2018) ‘Overexpression of PIK3R1 promotes hepatocellular carcinoma progression’, Biological Research, 51(1), pp. 1–10.
[42]
Yufu Tang et al. (2018) ‘Overexpression of PCK1 Gene Antagonizes Hepatocellular Carcinoma Through the Activation of Gluconeogenesis and Suppression of Glycolysis Pathways’, Cellular Physiology and Biochemistry, 47(1), pp. 344–355.
[43]
Cui, H.( 1,2,3 ) et al. (2021) ‘ENO3 Inhibits Growth and Metastasis of Hepatocellular Carcinoma via Wnt/β-Catenin Signaling Pathway’, Frontiers in Cell and Developmental Biology, 9.
[44]
Kacevska, M. et al. (2012) ‘DNA methylation dynamics in the hepatic CYP3A4 gene promoter’, Biochimie, 94(11), pp. 2338–2344.
[45]
Sciarra, A. et al. (2017) ‘CYP1A2 is a predictor of HCC recurrence in HCV-related chronic liver disease: A retrospective multicentric validation study’, Digestive & Liver Disease, 49(4), pp. 434–439.
Index Terms
- A Bayesian-based Approach for Identification of Potential Protein Biomarkers in Hepatocellular Carcinoma
Recommendations
Integrative computational modeling to unravel novel potential biomarkers in hepatocellular carcinoma
AbstractHepatocellular carcinoma (HCC) is a major health problem around the world. The management of this disease is complicated by the lack of noninvasive diagnostic tools and the few treatment options available. Better clinical outcomes can be achieved ...
Highlights- We analyze publicly available transcriptomics data from HCC tumor and non-tumor biopsies.
- We use meta analysis to find novel genes vital for HCC development/progression.
- Key reactions and pathways are also assessed with genome-...
Echinacoside inhibits hepatocellular carcinoma progression by targeting the miR-30c-5p/FOXD1/KLF12 axis
BACKGROUND:Hepatocellular carcinoma (HCC) is the third leading cause of cancer-attributed mortality and the primary liver malignancy in the world. Echinacoside is a phenylethanoid glycoside derived from traditional Chinese medicinal herbs which ...
Identification of chromosomal instability-associated genes as hepatocellular carcinoma progression-related biomarkers to guide clinical diagnosis, prognosis and therapy
AbstractHepatocellular carcinoma (HCC) is a type of cancer characterized by high heterogeneity and a complex multistep progression process. Significantly-altered biomarkers for HCC need to be identified. Differentially expressed genes and ...
Highlights- Hepatocellular carcinoma is characterized by high heterogeneity and complex multistep progression process.
Comments
Information & Contributors
Information
Published In
May 2023
313 pages
ISBN:9798400700385
DOI:10.1145/3608164
Copyright © 2023 ACM.
Permission to make digital or hard copies of all or part of this work for personal or classroom use is granted without fee provided that copies are not made or distributed for profit or commercial advantage and that copies bear this notice and the full citation on the first page. Copyrights for components of this work owned by others than the author(s) must be honored. Abstracting with credit is permitted. To copy otherwise, or republish, to post on servers or to redistribute to lists, requires prior specific permission and/or a fee. Request permissions from [email protected].
Publisher
Association for Computing Machinery
New York, NY, United States
Publication History
Published: 07 November 2023
Check for updates
Author Tags
Qualifiers
- Research-article
- Research
- Refereed limited
Funding Sources
- Xi'an Jiaotong-Liverpool University Key Programme Special Fund
- Natural Science Foundation of Jiangsu Province
Conference
ICBBT 2023
ICBBT 2023: 2023 15th International Conference on Bioinformatics and Biomedical Technology
May 26 - 28, 2023
Xi'an, China
Contributors
Other Metrics
Bibliometrics & Citations
Bibliometrics
Article Metrics
- 0Total Citations
- 34Total Downloads
- Downloads (Last 12 months)23
- Downloads (Last 6 weeks)1
Reflects downloads up to 02 Mar 2025
Other Metrics
Citations
View Options
Login options
Check if you have access through your login credentials or your institution to get full access on this article.
Sign inFull Access
View options
View or Download as a PDF file.
PDFeReader
View online with eReader.
eReaderHTML Format
View this article in HTML Format.
HTML Format